Journal profile · PEDIATRICS
Pediatric Health Medicine and Therapeutics
ISSN 1179-9927 · Dove Medical Press · United Kingdom
Pediatric Health Medicine and Therapeutics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.7 (journal website); JCR Q2 (journal website); fully open access; APC about USD 3,230; median 137 days to acceptance (80 articles, last 24 months); acceptance rate 24% (journal website); 32 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Pediatric Health Medicine and Therapeutics is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Child Nutrition and Water Access, Global Maternal and Child Health and Neonatal Respiratory Health Research, together about 33.4% of its articles. Its main subfields are Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Professor Laurens Holmes, Jr Pediatric Health, Medicine and Therapeutics is an international, peer-reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries. All aspects of pediatric and adolescent health maintenance, preventative measures, disease treatment interventions, and studies investigating the poor outcomes for some treatments, are addressed within the journal.One of the journal’s aims is to encompass research that facilitates our understanding of interventions in addressing unequal treatment that results in unequal outcomes of care across diverse pediatric and adolescent populations, thus narrowing and ultimately removing health disparities. With this focus, articles are invited from researchers, clinicians and policy advocates on characterization, epidemiology, control and elimination of disparities (race, ethnicity, sex, sexual orientation, language, disability, geographic locale) in childhood and adolescent morbidity (incidence, prevalence), access and utilization of care, and mortality, as well as studies on policies and intervention as evidence-based findings on pediatric and adolescent health disparities narrowing and elimination.The adolescent part of the journal follows WHO guidelines which define adolescents as those between the ages of 10 and 19 (https://www.who.int/southeastasia/health-topics/adolescent-health).Pediatric Health, Medicine and Therapeutics will no longer consider meta-analyses for publication.Practitioners from all disciplines are invited to submit their work as well as healthcare researchers and patient support groups. Areas covered include: Physical and mental development Behavioural issues Pathologies and treatment interventions Prevalence and incidence studies Diet and nutrition Outcome studies, patient satisfaction, compliance, and adherence Specific drug handling, efficacy, and safety issues Drug development programs Patient and health education programs and studies Treatment issues, including health issues affecting young people with cancer Challenges when transitioning from adolescent to adult care Updated 5 August 2025
From the journal's Aims & Scope
Research area (LetPub): PEDIATRICS
Editor-in-chief Laurens HolmesPublisher website
Editorial board by country: none in mainland China; most named India 9, United States 4, Hong Kong, China 2, Australia 2, Türkiye 2 (21 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Child Nutrition and Water AccessNursing17%
- Global Maternal and Child HealthMedicine9.9%
- Neonatal Respiratory Health ResearchMedicine6.5%
- Breastfeeding Practices and InfluencesMedicine5.3%
- Pneumonia and Respiratory InfectionsMedicine4.8%
- Iron Metabolism and DisordersMedicine4.1%
- Infant Development and Preterm CareMedicine4.1%
- Respiratory viral infections researchMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pediatrics | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pediatrics | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.7Publisher website ·
- h-index
- 38OpenAlex ·
- i10-index
- 208OpenAlex ·
- 2-year mean citedness
- 1.78OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 32LetPub ·
- Downloads per year (publisher)
- 98,065Publisher website ·
Articles by year OpenAlex count · 460 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 43 | 43 | 0 |
| 2025 | 32 | 32 | 51 |
| 2024 | 38 | 38 | 150 |
| 2023 | 43 | 43 | 415 |
| 2022 | 35 | 35 | 421 |
| 2021 | 53 | 53 | 882 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
137 daysMedian, submission to acceptance · P25–P75 112 days – 182 days
- Acceptance to online
- median 12 days (80 articles)
- Submission to online
- median 155 days
- Sample
- 80 articles with submission and acceptance dates (82 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 24%Publisher website ·
- Desk decision
- 74 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,230 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Policy excerpts from the journal's websitePeer review, Plagiarism
- Peer review
Member of and subscribes to the principles of COPE Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- Plagiarism
All submitted manuscripts are checked for plagiarism using Crossref Similarity Check (powered by iThenticate). Model summary
Please be aware that Dove Medical Press checks ALL submitted manuscripts for plagiarism. We use Crossref Similarity Check (powered by iThenticate).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1179-9927
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Pediatric Health Medicine and Therapeutics
What CAS zone is Pediatric Health Medicine and Therapeutics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pediatric Health Medicine and Therapeutics is in Zone 4 of Medicine, and in Zone 3 of the minor category Pediatrics. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pediatric Health Medicine and Therapeutics?
The journal's website gives an impact factor of 2.7 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 38.
How long does peer review take at Pediatric Health Medicine and Therapeutics?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 137 days (interquartile range 112–182 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 24%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Pediatric Health Medicine and Therapeutics in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of Pediatric Health Medicine and Therapeutics based?
Of the 21 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (9), United States (4) and Hong Kong, China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Pediatric Health Medicine and Therapeutics?
According to LetPub and DOAJ records, Pediatric Health Medicine and Therapeutics is indexed in ESCI and DOAJ.
Is Pediatric Health Medicine and Therapeutics open access, and what is the APC?
Pediatric Health Medicine and Therapeutics is a fully open-access journal. APC about USD 3,230.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .